ArticleJournal of extracellular vesicles2026
Neuronal Apoptotic Bodies Facilitate Japanese Encephalitis Virus Infection and Pathogenicity.
Article in Journal of extracellular vesicles, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Japanese encephalitis (JE) caused by Japanese encephalitis virus (JEV) infection remains one of the major types of viral encephalitis. The mechanisms underlying JEV infection and pathogenesis have not been fully elucidated, resulting in the absence of specific therapies for JE. Neuronal apoptosis is a well-established outcome of JEV infection; however, its secondary contributions to JE pathogenesis remain largely uncharacterized. Here, we demonstrate that apoptotic bodies (ApoBDs) derived from JEV-infected neurons package infectious JEV particles, facilitating viral transmission between neurons, as well as between neurons and microglia. Further investigations revealed that microglia predominantly internalize the ApoBDs via phagocytosis and dynamin 2-dependent endocytosis. Moreover, lipids, rather than nucleic acids or proteins, are the key pro-inflammatory constituents of ApoBDs. Subsequent studies demonstrated that ApoBDs activate microglia through the TLR2/TLR4-NF‑κB signalling. In vivo experiments showed that JEV-loaded ApoBDs elicit significantly more severe neuroinflammation and pathological lesions compared to ApoBD-free virions. These findings underscore the non-negligible contribution of neuron-derived ApoBDs to JEV pathogenesis, providing valuable insights for the development of novel therapeutic strategies against JE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.